Recursion (RXRX) acquires full rights to oral HPP treatment REV102
Go back to Recursion (RXRX) acquires full rights to oral HPP treatment REV102| (NASDAQ: RLYB) | Delayed: 17.00 +0.23 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.77 | 52 Week High | $ | |||
| Open | $17.12 | 52 Week Low | $ | |||
| Day High | $17.20 | P/E | N/A | |||
| Day Low | $16.86 | EPS | $ | |||
| Volume | 17,779 | |||||
| (NASDAQ: RXRX) | Delayed: 3.50 +0.41 (13.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.09 | 52 Week High | $ | |||
| Open | $3.28 | 52 Week Low | $ | |||
| Day High | $3.50 | P/E | N/A | |||
| Day Low | $3.19 | EPS | $ | |||
| Volume | 30,322,008 | |||||
